Creo Medical (UK) Today
| CREO Stock | 16.13 0.50 3.01% |
Performance0 of 100
| Odds Of DistressOver 53
|
Creo Medical is selling for under 16.13 as of the 25th of November 2024; that is 3.01 percent decrease since the beginning of the trading day. The stock's lowest day price was 16.0. Creo Medical has 53 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Creo Medical Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Creo Medical is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 412.15 M outstanding shares. More on Creo Medical Group
Moving together with Creo Stock
| 0.87 | SMSD | Samsung Electronics | PairCorr |
| 0.88 | SMSN | Samsung Electronics | PairCorr |
| 0.76 | HYUD | Hyundai Motor | PairCorr |
| 0.94 | RIGD | Reliance Industries | PairCorr |
Moving against Creo Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Creo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Creo Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Creo Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Craig Gulliford | ||||
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Creo Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Creo Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCreo Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Creo Medical's financial leverage. It provides some insight into what part of Creo Medical's total assets is financed by creditors.
| |||||
Creo Medical Group (CREO) is traded on London Exchange in UK and employs 278 people. Creo Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 68.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Creo Medical's market, we take the total number of its shares issued and multiply it by Creo Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Creo Medical Group operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 412.15 M outstanding shares.
Creo Medical generates negative cash flow from operations
Check Creo Medical Probability Of Bankruptcy
Ownership AllocationCreo Medical holds a total of 412.15 Million outstanding shares. Creo Medical Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Creo Ownership Details
Creo Medical Group Risk Profiles
Although Creo Medical's alpha and beta are two of the key measurements used to evaluate Creo Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.22 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.73 | |||
| Risk Adjusted Performance | (0.16) |
Creo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Creo Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Creo Medical Corporate Executives
Elected by the shareholders, the Creo Medical's board of directors comprises two types of representatives: Creo Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creo. The board's role is to monitor Creo Medical's management team and ensure that shareholders' interests are well served. Creo Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creo Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pr Hancock | CTO Founder | Profile |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.